AI Article Synopsis

  • Helicobacter pylori infection and NSAID usage are significant risk factors for developing gastric ulcers, often linked to chronic gastritis.
  • Treating Helicobacter pylori not only helps heal existing gastric ulcers but also prevents future complications and recurrences of the condition.
  • For NSAID-related gastric ulcers, patients typically require antisecretory therapy for effective management.

Article Abstract

Helicobacter pylori infection and the use of non-steroidal anti-inflammatory drugs (NSAID) are considered to be the two major risk factors implicated in the development of gastric ulcer. Helicobacter pylori infection related chronic gastritis is known to be the underlying condition which may lead to gastric ulcer. Development of gastric ulcer as the consequence of underlying chronic gastritis is caused by many factors. Treating Helicobacter pylori infection entails the healing of gastric ulcer, it concomitantly prevents recurrences and complications of gastric ulcer, primarily bleeding, and changes the natural course of gastric ulcer disease. Continuation of antisecretory maintenance treatment beyond ulcus healing and eradication of Helicobacter pylori infection is only indicated in risk groups. Patients with gastric ulcer caused by NSAID use are managed with antisecretory therapy.

Download full-text PDF

Source

Publication Analysis

Top Keywords

gastric ulcer
28
helicobacter pylori
20
pylori infection
16
ulcer helicobacter
8
development gastric
8
chronic gastritis
8
gastric
7
ulcer
7
helicobacter
5
pylori
5

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!